COVID earnings

Before we begin our comments on Abbott’s earnings released this morning a shout out to the diabetes industry and their efforts to help patients during this difficult time. Just this morning Insulet announced a financial assistance program offering a FREE 6-month supply of pods for patients who have been adversely impacted by the crisis. Insulet joins Novo Nordisk, Lilly and others who have offered either FREE drugs and/or devices. The business of diabetes may be about money, but it is great to see these companies put the patient ahead of profits during this difficult time.

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.